0.06 - 0.07
0.06 - 0.24
4.46M / 3.59M (Avg.)
-1.65 | -0.04
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-85.88%
G&A reduction while SMR.AX shows 0.00% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-63.49%
Operating expenses reduction while SMR.AX shows 0.00% growth. Joel Greenblatt would examine advantage.
-63.49%
Total costs reduction while SMR.AX shows 0.00% growth. Joel Greenblatt would examine advantage.
No Data
No Data available this quarter, please select a different quarter.
-59.91%
D&A reduction while SMR.AX shows 0.00% growth. Joel Greenblatt would examine efficiency.
136.73%
EBITDA growth exceeding 1.5x SMR.AX's 13.48%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
43.03%
Income change of 43.03% while SMR.AX is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
642.93%
Other expenses change of 642.93% while SMR.AX maintains costs. Bruce Berkowitz would investigate control.
93.56%
Income change of 93.56% while SMR.AX is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
-114.78%
Tax expense reduction while SMR.AX shows 0.00% growth. Joel Greenblatt would examine advantage.
98.33%
Income change of 98.33% while SMR.AX is flat. Bruce Berkowitz would examine quality.
No Data
No Data available this quarter, please select a different quarter.
98.37%
EPS growth while SMR.AX declines. John Neff would investigate advantages.
98.37%
Diluted EPS growth while SMR.AX declines. John Neff would investigate advantages.
4.91%
Share count change of 4.91% while SMR.AX is stable. Bruce Berkowitz would verify approach.
4.91%
Diluted share change of 4.91% while SMR.AX is stable. Bruce Berkowitz would verify approach.